Akebia Therapeutics: Still Bullish On Vafseo As Auryxia's Revenues Decline
Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia’s declining revenues. See why I ...
Wall Street Journal24d
Label Vie
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Amgen Q4 Earnings: Strong Pipeline And Label Expansions Justify Buy Rating
Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...
Crain's Cleveland Business6d
Smucker selling two more sweet treat brands as it focuses on Hostess
Last October, Smucker agreed to sell its Voortman cookie brand to Second Nature Brands, a snack maker controlled by CapVest ...
Wall Street Journal23d
Taylor Swift's Record Label Is Headed for a U.S. Listing
Shares in Universal Music, the world's largest record label, could soon be listed on a U.S. exchange, as a result of a $500 million stock offering by Bill Ackman's Pershing Square. The hedge-fund ...
Avery Dennison: Buy Rating Backed by Growth in Intelligent Labels and Operational Improvements
Stifel Nicolaus analyst Lars Kjellberg maintained a Buy rating on Avery Dennison (AVY – Research Report) yesterday and set a price target of ...